Digital Therapeutics (DTx) Market

1
Digital Therapeutics (DTx) Market Trends, Size,
Share, Demands, Overview, Growth, Revenue and
Forecast to 2030
sales_at_delvens.com www.delvens.com
2
Sternal Closure Systems Market Trends Forecast
Till 2030
Digital Therapeutics (DTx) Market, by Product
(Software and Devices), Sales Channel
(Business-to-Business and Business-to-Consumers),
Application (Diabetes, Obesity, Cardiovascular
Disease (CVD), Central Nervous System (CNS),
Disease Respiratory Disease, Smoking Cessation,
Gastrointestinal Disorder (GID) and Others) and
region (North America, Europe, Asia-Pacific,
Middle East and Africa and South
America).
Request For Free Sample Report
https//www.delvens.com/get-free-sample/digital-th
erapeutics-dtx-market
sales_at_delvens.com
www.delvens.com
3
Market Overview
Digital therapy provides patients with
evidence-based therapeutic interventions. It is
provided with software and devices designed to
manage or treat medical conditions. Digital
therapy software can be used alone or in
conjunction with another device, medication or
treatment to achieve patient treatment and health
outcomes. The design, clinical validation,
usability and data security of digital therapies
are based on state-of-the-art technology
according to best practices. These products have
been tested and approved by regulatory
authorities before use. In addition, digital
therapies provide patients, healthcare providers
and payers with smart, easy-to-use tools to treat
a variety of diseases through interventions such
as high-quality, safe and effective
evidence-based cards. Purchase this Report
https//www.delvens.com/checkout/digital-therapeut
ics-dtx-market
sales_at_delvens.com
www.delvens.com
4
Market Overview
The increase in the use of smartphones and
tablets and health applications, the need to
control healthcare costs, significant benefits to
the entire process of treatment and the increase
in the incidence of chronic diseases are driving
the growth of the global digital therapy market.
The major factors driving the market growth are
the increase in the incidence of preventable
chronic diseases and the increase in public
health funding. Emerging markets also offer
companies significant growth opportunities in the
coming years. Moreover, strong potential
products coming to the market during the forecast
period are also beneficial for market
participants. Factors such as cost-effectiveness
of digital health technologies for providers and
patients and increasing need for integrated
health systems and patient-centric care are
expected to drive market growth during the
forecast period.
sales_at_delvens.com
www.delvens.com
5
Key Findings
The Digital Therapeutics (DTx) market is
segmented into various segments such product,
sales channel, application and region The
Product segment is further fragmented into
Software and Devices. The software segment is the
largest and fastest growing segment that
dominated the market and is expected to continue
this trend during the forecast period due to
continuous improvement of firmware and device
softwares. The Sales Channel segment is further
bifurcated into Business-to-Business and
Business-to-Consumers. The business-to-consumers
segment is the largest and the fastest growing
segment which exhibited the highest growth and is
expected to continue this trend during the
forecast period.
sales_at_delvens.com
www.delvens.com
6
Key Findings
The Application segment is further bifurcated
into Diabetes, Obesity, Cardiovascular Disease
(CVD), Central Nervous System (CNS), Disease
Respiratory Disease, Smoking Cessation,
Gastrointestinal Disorder (GID) and Others. The
market is also divided into various regions such
as North America, Europe, Asia-Pacific, South
America, and Middle East and Africa. North
America is estimated to account for the largest
market share during the forecast period. Inquire
Before Buying https//www.delvens.com/Inquire-bef
ore-buying/digital-therapeutics-dtx-market
sales_at_delvens.com
www.delvens.com
7
Competitive Landscape

• Omada Health, Inc.
• Welldoc, Inc
• Kaia Health
• 2MORROW, Inc.
• Proteus Digital Health, Inc.
• Akili Interactive Labs, Inc.
• Pear Therapeutics, Inc.
• Resmed, Inc. (Propeller Health)
• Fitbit, Inc. (Twine Health, Inc.)
• GAIA AG
• Limbix Health, Inc.

• Click Therapeutics, Inc.
• Livongo Health, Inc.
• Voluntis, Inc.
• Medtronic Plc.
• Happify, Inc.
• Canary health
• Noom, Inc.
• HYGIEIA
• DarioHealth Corp.
• BigHealth

sales_at_delvens.com
www.delvens.com
8
Recent Developments
In February 2022, DynamiCare Health Inc., a
digital therapeutics and telehealth company
received Breakthrough Device Designation for
DCH-001 from the United States Food and Drug
Administration (FDA).  In May 2021, Eli Lilly
and Company signed strategic international
agreements with four companies to advance
connected solutions and streamline diabetes care
management for individuals living with the
disease outside of the United States.
sales_at_delvens.com
www.delvens.com
9
Contact Information
About Us Delvens is a strategic advisory and
consulting company headquartered in New Delhi,
India. The company holds expertise in providing
syndicated research reports, customized research
reports and consulting services. Delvens
qualitative and quantitative data is highly
utilized by each level from niche to major
markets, serving more than 1K prominent companies
by assuring to provide the information on
country, regional and global business
environment. We have a database for more than 45
industries in more than 115 major countries
globally. Contact Us 44-20-3290-6466 1
214-377-1144 sales_at_delvens.com
sales_at_delvens.com
www.delvens.com